Foresite Capital Fund VI, L.P. 13D/13G Filings for CASI Pharmaceuticals, Inc. (CASI)

Foresite Capital Fund VI, L.P. 13D and 13G filings for CASI Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-06-20
9:00 pm
Purchase
2024-06-1013GCASI Pharmaceuticals, Inc.
CASI
Foresite Capital Fund VI, L.P.1,309,383
9.800%
1,309,383increase
(New Position)
Filing